Filing Details

Accession Number:
0001209191-19-043855
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-31 16:21:20
Reporting Period:
2019-07-29
Accepted Time:
2019-07-31 16:21:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1447362 Castle Biosciences Inc CSTL Services-Medical Laboratories (8071) 770701744
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1623049 G. Mara Aspinall C/O Castle Biosciences, Inc.
820 S. Friendswood Drive, Suite 201
Friendswood TX 77546
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-07-29 14,093 $0.00 37,723 No 4 C Direct
Common Stock Acquisiton 2019-07-29 3,125 $16.00 40,848 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series F Preferred Stock Disposition 2019-07-29 17,180 $0.00 14,093 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
Footnotes
  1. Every 1.219 outstanding shares of Preferred Stock automatically converted into 1 share of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration, with cash paid for any fractional shares. The Preferred Stock had no expiration date.
  2. Represents a purchase from the underwriters in the Issuer's IPO.